Takeda to buy out Abbott in U.S. joint venture, source says

03/19/2008 | Bloomberg1 · Reuters

Japanese drugmaker Takeda Pharmaceutical Co. Ltd. is reportedly trying to buy Abbott Laboratories' 50% stake in their U.S. venture for $5 billion. The companies declined to comment on the rumored buyout, which would have Takeda taking over TAP Pharmaceutical Products, but with Abbott getting the venture's prostate cancer division and the rights to some of Takeda's drug candidates.

View Full Article in:

Bloomberg1 · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC